Tradestie Institutional Equity Comparison Engine

DMIIU vs DNMXU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DMIIU Overall Edge

DMIIU Captures Institutional Edge (1โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Drugs Made In America Acquisition II Corp. Unit (DMIIU) driven by superior Momentum & Technical. Fundamentally, DMIIU trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus DNMXU at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, DMIIU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DNMXU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
DMIIU N/M vs DNMXU N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner DMIIU
1Y +2.7% vs +0.7% ยท 52W Pos 38% vs 15%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
DMIIU NASDAQ
Drugs Made In America Acquisition II Corp. Unit
Institutional Equity
$10.26
+0.29% 1D
Market Cap N/A
1M Return +0.98%
1Y Return +2.7%
Forward P/E N/M
Unified AI Score
65.1 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0
DNMXU US Equity
DNMXU
Institutional Equity
$10.19
+0.2% 1D
Market Cap N/A
1M Return +0.3%
1Y Return +0.69%
Forward P/E N/M
Unified AI Score
55.2 / 100 HOLD
Tech 54.0 Fund 51.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DMIIU +2.7% DNMXU +0.69% Spread: +1.74 pp (DMIIU Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DMIIU TTM Op. Margin: N/A DNMXU TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DMIIU vs DNMXU. Trailing 12-month operating profitability (DMIIU N/A vs DNMXU N/A) and valuation multiples (DMIIU N/M vs DNMXU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DMIIU (2) vs DNMXU (1)
Institutional Metric DMIIU DNMXU Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 38% ($10โ€“$11) 15% ($10โ€“$11) Stronger Trend DMIIU
Beta / 30D Volatility Risk Regime -0.01ฮฒ ยท 4% Vol -0.00ฮฒ ยท 3% Vol Lower Realized Risk DNMXU
Unified Institutional Score Composite Signal 65.1 / 100 (BUY) 55.2 / 100 (HOLD) Higher Composite DMIIU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DMIIU vs DNMXU Buy Guide
DMIIU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DMIIU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DNMXU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DNMXU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DMIIU nor DNMXU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.